Pioneering a new path in biotechnology, NanoMosaic is a medtech company that creates nanoneedles for biological and medical research. The MosaicNeedle is supported by the software platform Tessie. Together they help to create highly accurate and single molecule-sensitive samples for researchers.
The company has enjoyed considerable funding from biotech investors and launched its Tessie platform in 2022. Having exported its technology to leading hospitals and research institutes, NanoMosaic’s continued success indicates a thriving biotech sector that still has plenty of innovation opportunities.
Steph
Company Specialist at Welcome to the Jungle